Clinical Manifestation and Characteristics of COVID-19 in Pregnants: A Retrospective, Single-Center Study

Year 2022, Volume: 12 Issue: 02, 38 - 46, 15.06.2022

Esmeray Mutlu Yılmaz Eda Koksal Gökhan Unver Sercan Serin

https://doi.org/10.5799/jmid.1130058

Abstract

Objectives: Along with the COVID-19 pandemic, pregnant women have experienced COVID-19 symptoms of varying severity. Therefore, we aimed to show the clinical, laboratory, and radiological findings for three different trimesters in pregnant women diagnosed with COVID-19.
Methods: All hospitalized pregnant women with positive SARS-CoV-2 nucleic acid tests were included in this study. The severity of the disease was classified using the NIH Classification of Severity of Disease.
Results: None of the 206 participants were vaccinated. The number of asymptomatic or presymptomatic patients, those with mild, moderate, and severe disease, was 73(35.4%), 59(28.6%), 68 (33.1%), and 6 (2.9%), respectively. The gestational age of symptomatic patients was lower than that of asymptomatic patients (29 vs. 37 weeks) (p= 0.001). The incidence of pneumonia increased with the trimester of pregnancy increased (p<0.001). Sixty-six of the pregnancies (32.0%) ended with term births, and 11 (0.5%) gave premature birth. Three pregnancies resulted in miscarriage (1.4%), and one(0.4%) resulted in intrauterine fetal death. Of the preterm deliveries, nine(64.3%) had pneumonia. There was no significant relationship between the disease severity and delivery time (p=0.075), but a significant relationship between the disease severity and the delivery mode. Expected vaginal delivery occurred in 18 asymptomatic patients (72%), whereas cesarian/section was performed in 75.6% (n=31) of symptomatic patients (p<0.001).
Conclusion: This study reflects the natural course of COVID-19 since our patients were not vaccinated. We think the results will be better with the increase in vaccination rates.

Keywords

Pregnancy, COVID-19, Pandemic, Pneumonia

References

• 1. Mei Y, Luo D, Wei S, Liao X, Pan Y, Yang X, Lin Y: Obstetric management of COVID-19 in pregnant women. Front Microbiol 2020, 11:1186.
• 2. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V: Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American journal of obstetrics & gynecology MFM 2020, 2(2):100107.
• 3. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstetr Gynecol 2004, 191(1):292-297.
• 4. Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-related mortality resulting from influenza in the United States during the 2009–2010 pandemic. Obstetr Gynecol 2015, 126(3):486.
• 5. Thompson JL, Nguyen LM, Noble KN, Aronoff DM. COVID-19-related disease severity in pregnancy. Am J Reprod Immunol 2020, 84(5):e13339.
• 6. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22–June 7, 2020. MMWR 2020, 69(25):769.
• 7. Li N, Han L, Peng M, Lv Y, et al: Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study. Clin Infect Dis 2020, 71(16):2035-2041.
• 8. Clinical Spectrum of SARS-CoV-2 Infection [https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/]
• 9. Guan W-j, Ni Z-y, Hu Y, et al: Clinical Characteristics of Coronavirus Disease 2019 in China. N Eng J Med 2020, 382(18):1708-1720.
• 10. Lu L, Zhong W, Bian Z, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect 2020.
• 11. Vouga M, Favre G, Martinez-Perez O, Pomar L, Acebal LF, Abascal-Saiz A, Hernandez MRV, Hcini N, Lambert V, Carles G: Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Scient Report 2021, 11(1):1-11.
• 12. Wastnedge EAN, Reynolds RM, van Boeckel SR, et al. Pregnancy and COVID-19. Physiol Rev 2021, 101(1):303-318.
• 13. Khalil A, Hill R, Ladhani S, Pattisson K, O’Brien P: Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstetr Gynecol 2020, 223(2):296-297.
• 14. Pineles BL, Goodman KE, Pineles L, et al. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19. Ann Intern Med 2021.
• 15. Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr 2021; 175(8):817-826.
• 16. Blitz M, Rochelson B, Meirowitz N, Prasannan L, Rafael T: Maternal mortality among women with coronavirus disease 2019. Am J Obstetr Gynecol 2019; 223(4):595-599.e5.
• 17. Chen L, Li Q, Zheng D, et al: Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. N Eng J Med 2020; 382(25):e100.
• 18. Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13):1239-1242.
• 19. Chen H, Guo J, Wang C, et al: Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395(10226):809-815.
• 20. Barry M, Barry MA: Coronaviruses in pregnant women in Saudi Arabia: A systematic comparative review of MERS-CoV and SARS-CoV-2. Asian Pacific J Reproduct 2021; 10(3):97.
• 21. Koyuncu K, Yasemin A, Sakin Ö, et al. COVID-19 in pregnant women-a retrospective cohort study. Samsun Sağlık Bilimleri Dergisi, 6(1):181-186. (Turkish)
• 22. Özdemir YE, Balkan İİ, Bayramlar OF, et al: Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia. Mikrobiol Bullet 2021, 55(3):342-356.
• 23. Abu-Amara J, Szpecht D, Al-Saad SR, Karbowski LM: Contracting COVID-19 in the first and second trimester of pregnancy: what we know–a concise qualitative systematic review. Arch Med Sci 2021;17(6):1548-1557.
• 24. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9(1):51-60.
• 25. Manal M, Abdelilah E, Mohammed M, Rajae A, Amine BM, Houssam B, Naima A, Brahim H: Lymphopenia in Covid-19: A single center retrospective study of 589 cases. Ann Med Surg (Lond) 2021; 69:102816.
• 26. Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett 2020; 225:31-32.
• 27. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID‐19. Am J Hematol 2020; 95(7):834-847.
• 28. Karimi L, Makvandi S, Vahedian-Azimi A, Sathyapalan T, Sahebkar A: Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis. J Pregnancy 2021; 2021:8870129.
• 29. Takemoto MLS, Menezes MO, et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet 2020; 151(1):154-156.
• 30. Ferrazzi E, Frigerio L, Savasi V, et al. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis. BJOG: An Intern J of Obstetr Gynaecol 2020; 127(9):1116-1121.
• 31. Zhang L, Jiang Y, Wei M, et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi 2020; 55(3):166-171. (Chinese)